Influence of broad-spectrum antibiotic prophylaxis on intracranial pressure monitor infections and subsequent infectious complications in head-injured patients

Surgical Infections

Volumn 7, Issue 5, 2006, Pages 409-417

  May, Addison K ^a,b   Fleming, Sloan B ^a   Carpenter, Robert O ^a   Diaz Jr , Jose J ^a   Guillamondegui, Oscar D ^a   Deppen, Stephen A ^a   Miller, Richard S ^a   Talbot, Thomas R ^a   Morris, John A ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN; MEROPENEM; METICILLIN; METRONIDAZOLE; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TICARCILLIN; TOBRAMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DEVICE INFECTION; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HEAD INJURY; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTRACRANIAL PRESSURE MONITORING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RISK REDUCTION; SCORING SYSTEM;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; CRANIOCEREBRAL TRAUMA; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INTRACRANIAL PRESSURE; MALE; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION;

EID: 33845253330     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2006.7.409     Document Type: Article

References (21)

1. McGraw CP. Continuous intracranial pressure monitoring: Review of techniques and presentation of method. Surg Neurol 1976;3:149-155.
2. Prabhu VC, Kaufman HH, Voelker JL, et al. Prophylactic antibiotics with intracranial pressure monitors and external ventricular drains: A review of the evidence. Surg Neurol 1999;52:226-236.
3. Arabi Y, Memish ZA, Balkhy HH, et al. Ventriculostomy-associated infections: Incidence and risk factors. Am J Infect Control 2005;33:137-143.
4. Aucoin PJ, Kotilainen HR, Gantz NM, et al. Intracranial pressure monitors: Epidemiologic study of risk factors and infections. Am J Med 1986;80:369-376.
5. Rosner MJ, Becker DP. ICP monitoring: Complications and associated factors. Clin Neurosurg 1976; 23:494-519.
6. Alleyne CH Jr, Hassan M, Zabramski JM. The efficacy and cost of prophylactic and perioprocedural antibiotics in patients with external ventricular drains. Neurosurgery 2000;47:1124-1127.
7. Blomstedt GC. Results of trimethoprim-sulfamethoxazole prophylaxis in ventriculostomy and shunting procedures: A double-blind randomized trial. J Neurosurg 1985;62:694-697.
8. Flanagan PP. Prophylactic antibiotics in ventriculostomies: A randomized double-blinded pilot study: Preliminary report. In Riley DK, Bost JW, Wilson J, Whiting D, eds. Proceedings of the American Association of Neurologic Surgeons Annual Meeting, Minneapolis, MN. Poster 1373, 1996:262.
9. Jacobs DG, Westerband A. Antibiotic prophylaxis for intracranial pressure monitors. J Natl Med Assoc 1998;90:417-423.
10. Poon WS, Ng S, Wai S. CSF antibiotic prophylaxis for neurosurgical patients with ventriculostomy: A randomised study. Acta Neurochir (Wien) 1998;71 (Suppl):146-148.
11. Rebuck JA, Murry KR, Rhoney DH, et al. Infection related to intracranial pressure monitors in adults: Analysis of risk factors and antibiotic prophylaxis. J Neurol Neurosurg Psychiatry 2000;69:381-384.
12. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29-34.
13. Kollef MH. Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients. Clin Infect Dis 2000;31(Suppl 4):S131-S138.
14. Ariffin H, Navaratnam P, Mohamed M, et al. Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia. Int J Infect Dis 2000;4:21-25.
15. Chow JW, Fine MJ, Shlaes DM, et al. Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115: 585-590.
16. Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible. Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis 2003;36: 53-59.
17. Kollef MH, Ward S, Sherman G, et al. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med 2000;28:3456-3464.
18. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998;157: 531-539.
19. Clark NM, Patterson J, Lynch JP III. Antimicrobial resistance among gram-negative organisms in the intensive care unit. Curr Opin Crit Care 2003;9:413-423.
20. Clark NM, Hershberger E, Zervos MJ, Lynch JP III. Antimicrobial resistance among gram-positive organisms in the intensive care unit. Curr Opin Crit Care 2003;9:403-412.
21. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002;136:834-844.